The anti-herpes drug acyclovir can also directly slow down HIV infection by targeting the reverse transcriptase enzyme, researchers report. This beneficial effect does pose a risk though, as HIV-infected cells treated with acyclovir promote the emergence of multi-drug resistant HIV variants.